-
Sector Analysis
Three Possible Scenarios for MFN Implementation in the US: What Can Pharma Expect and What Are the Possible Strategies to Protect Revenue
Just over a year ago, US President Donald Trump signaled his intent to introduce international reference pricing (IRP) for medicines in the US through the May 2025 Most Favored Nation (MFN) executive order. Based on GlobalData's extensive repository of IRP knowledge and daily tracking of pricing and reimbursement developments around the world, in this strategic report GlobalData explores alternative scenarios for MFN implementation and what these mean for the pharmaceutical industry, with a particular focus on how to protect pharma...
-
Sector Analysis
Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape
Why Does the FSGS Therapeutics Market Matter? Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disease characterized by scarring of the glomeruli and can lead to progressive kidney dysfunction. The treatment landscape is undergoing a significant shift as disease-specific therapies emerge alongside established supportive and off-label treatment approaches. GlobalData’s Focal Segmental Glomerulosclerosis (FSGS): Market View provides a data-driven assessment of the current and future competitive landscape, combining Pharma Intelligence Center data with in-house analyst expertise. In 2025, there were 37,049...
-
Sector Analysis
Cannabis Market Summary, Competitive Analysis and Forecast to 2030
Global Cannabis industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2020-25, and forecast to 2030). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This...
-
Sector Analysis
Asia-Pacific (APAC) Cannabis Market Summary, Competitive Analysis and Forecast to 2030
Cannabis in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2020-25, and forecast to 2030). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This encompasses...
-
Sector Analysis
Europe Cannabis Market Summary, Competitive Analysis and Forecast to 2030
Cannabis in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2020-25, and forecast to 2030). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This encompasses...
-
Sector Analysis
North America Cannabis Market Summary, Competitive Analysis and Forecast to 2030
Cannabis in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2020-25, and forecast to 2030). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This...
-
Sector Analysis
South America Cannabis Market Summary, Competitive Analysis and Forecast to 2030
Cannabis in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2020-25, and forecast to 2030). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This...
-
Sector Analysis
Middle East and Africa (MEA) Cannabis Market Summary, Competitive Analysis and Forecast to 2030
Cannabis in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2020-25, and forecast to 2030). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed...
-
Consumer Insights
Industry Insights: How Dietary Supplements Have Evolved Beyond Traditional Health Management
This report highlights the shift in consumer preferences from traditional health supplements to modern formats designed to address specific health needs. As people become more health-conscious, they are increasingly seeking tailored, localized products that support longevity and overall vitality. Growing interest in these contemporary supplements is largely fueled by online marketing and easier access to health information through social media. The report explores consumer interest in nootropics, nutricosmetics, and cellular health supplements. As health and wellness become a higher priority...
-
Sector Analysis
IgA Nephropathy (Berger’s Disease): Market View, Current and Future Competitive Landscape
This report provides a data-driven overview of the current and future competitive landscape in IgA Nephropathy (Berger’s Disease) Therapeutics. • In 2025, there were 102,155 incident cases of Berger's disease in the 16 countries covered in GlobalData’s epidemiology forecast. • Berger's disease is primarily managed with blood pressure medication like ACE inhibitors or ARBs to protect the kidneys. For high-risk patients, corticosteroids and newer targeted therapies are also available to slow the disease's progression. • The Berger's disease pipeline holds...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.